Skip to main content
. 2021 May 12;2(5):270–281. doi: 10.1016/j.cvdhj.2021.05.003

Table 2.

Association of clinical characteristics with average admission heart rate and change in average daily heart rate across 30 days postdischarge (in comparison with patients without the designated characteristic)

Clinical characteristics Relative diff. in mean admission HR 95% CI P Relative diff. in mean daily HR change 95% CI P
Medical history
 Current/previous smoker 0.202 -3.33 to 3.73 .911 0.001 -0.183 to 0.185 .990
 Hypertension -3.18 -7.05 to 0.690 .107 0.190 0.002 to 0.378 .048
 T2DM 1.21 -2.31 to 4.72 .500 0.220 0.044 to 0.395 .014
 Prior MI 2.67 -3.65 to 8.98 .409 0.184 -0.109 to 0.477 .219
 Prior CABG 8.98 1.59 to 16.37 .017 0.255 -0.043 to 0.552 .093
 Stroke 1.10 -7.28 to 9.47 .797 0.229 -0.127 to 0.585 .207
 Hyperlipidemia 0.125 -3.64 to 3.89 .948 0.179 0.002 to 0.355 .047
 Depression 12.5 4.29 to 20.6 .003 0.319 -0.155 to 0.793 .187
Admission characteristics
 Diagnosis of STEMI 0.984 -2.77 to 4.73 .607 -0.067 -0.251 to 0.118 .479
 LVEF <40% 2.89 -2.62 to 8.39 .304 0.039 -0.201 to 0.279 .753
 CABG performed 2.41 -2.31 to 7.13 .317 0.049 -0.198 to 0.296 .697
 PCI performed -2.04 -6.69 to 2.62 .391 -0.066 -0.294 to 0.163 .573
 Transfusion performed -0.026 -5.76 to 5.71 .993 0.068 -0.182 to 0.317 .595
 Incomplete revascularization 0.408 -6.37 to 7.19 .906 -0.025 -0.334 to 0.284 .875
 Development of heart failure 2.50 -3.47 to 8.47 .412 0.287 -0.002 to 0.576 .052
Non-BB/CCB medications
 ACE inhibitors/ARBs -0.551 -4.74 to 3.64 .797 -0.007 -0.194 to 0.180 .942
 Anticoagulants 9.64 4.11 to 15.16 .001 -0.253 -0.517 to 0.010 .059
 Diuretics 5.61 1.60 to 9.61 .006 0.096 -0.109 to 0.302 .358
 ADP receptor inhibitors 2.06 -4.17 to 8.29 .517 -0.234 -0.590 to 0.123 .198

BB = beta-blocker; CCB = calcium channel blocker; other abbreviations as in Table 1.

After adjusting for CABG in T2DM association analysis.

After adjusting for T2DM in CABG association analysis.